NB
JAZZ icon

Nicolet Bankshares’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nicolet Bankshares’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Buy
+18,224
New +$3.18M 0.13% 132

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Nicolet Bankshares's JAZZ Position: Q1 2026 in Review

Nicolet Bankshares opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 18,224 shares worth $3.45M. The stake represents 0.13% of the portfolio and ranks #132 among its holdings.

570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Nicolet Bankshares held 18,224 shares of Jazz Pharmaceuticals worth $3.45M as of Q1 2026.
  • Jazz Pharmaceuticals was a new Nicolet Bankshares position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.13% of Nicolet Bankshares's portfolio in Q1 2026, its #132 holding.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Nicolet Bankshares's 13F filing for Q1 2026, filed 14 May 2026.